Donor lymphocyte infusion for prophylaxis and treatment of relapse in pediatric hematologic malignancies after allogeneic hematopoietic stem cell transplant.

J Chin Med Assoc · 2023 · PMC12718955 · PMID 37697465

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

borderline significancep = 0.051so close (0.05 < p ≤ 0.1)

Only the patients who had received dose-escalated DLI exhibited a lower degree of cGVHD severity than did the other patients with borderline significance ( p = 0.051; Fig. 2 H).

also in 4,324 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.